Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ESMO 2025
Biotech
Moderna cancer push 'makes sense' when HHS skeptical of vaccines
Moderna’s efforts to advance its cancer pipeline “make sense” in the current political climate, the company’s oncology chief told Fierce.
James Waldron
Oct 22, 2025 3:00am
Lilly oncology head weighs in on FDA cancer drug policies
Oct 21, 2025 11:53am
ESMO: The ADC 'rollercoaster' rides on with next-gen meds
Oct 21, 2025 3:00am
Fierce Pharma
Merck grows more ambitious about 'workhorse' TROP2 ADC
Oct 20, 2025 4:00pm
ESMO: Daiichi, Merck move ovarian cancer ADC toward pivotal test
Oct 20, 2025 10:45am
ESMO: Exelixis' TKI reduces risk of death by 20%
Oct 20, 2025 2:30am